The study then classified LCNEC as SCLC-like if RB1 or TP53 were mutated or had copy number loss and as NSCLC-like LCNEC if patients did not have RB1 and TP53 co-alterations (23). Here, RB1 is linked to non-small cell lung carcinoma.